(Press-News.org) SAN DIEGO (March 14, 2015) -- Adding the antiplatelet drug ticagrelor to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke, with the benefit appearing to accrue for nearly three years, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
The double-blind PEGASUS-TIMI 54 trial recruited 21,162 patients who had experienced a heart attack in the previous one to three years. Each had another factor, such as age or diabetes, that put them at risk for a second heart attack. The patients, from 1,144 sites in 31 countries, were randomly assigned to a twice-daily regimen of ticagrelor at 90 mg, ticagrelor at 60 mg or placebo.
Both ticagrelor doses reduced the chances of cardiovascular death, heart attack or stroke, the study's primary endpoint, with a 15 percent reduction in the 90-mg group and a 16 percent reduction in the 60-mg group compared to the placebo group.
"The benefit we saw was remarkably consistent across the individual components of the endpoint and in all the major subgroups of patients," said Marc S. Sabatine, M.D., M.P.H., chair of the TIMI Study Group, a senior physician in the Cardiovascular Division at Brigham and Women's Hospital and Harvard Medical School in Boston, and the study's principal investigator. "Moreover, we followed patients for an average of just under three years, and our event curves continue to spread out over time, suggesting that the benefit continues to accrue over time."
After a heart attack, standard practice calls for putting patients on a lifetime regimen of daily aspirin to prevent clotting and reduce the chance of another heart attack. Previous studies have shown a benefit in adding a second antiplatelet drug like ticagrelor, from a class called P2Y12 inhibitors, but they investigated the additional therapy for only a year, leaving unanswered the question of whether patients would benefit from continuing this treatment longer.
The twice-daily 90-mg dose of ticagrelor is already approved for patients with acute coronary syndrome. Researchers included a lower dose in this study, to study whether platelet inhibition needed two years after a heart attack might be different from what is needed two hours after a heart attack. Findings from a pharmacokinetic and pharmacodynamic substudy comparing the two dose levels will be presented at a later date.
With blood thinners such as ticagrelor, bleeding is the major side effect, and excess bleeding was seen in both treatment arms, though bleeding into the brain and fatal bleeding were not more common with ticagrelor, Sabatine said. Shortness of breath, called dyspnea, was more common with ticagrelor than placebo. Bleeding led to discontinuation of ticagrelor in about 7 percent of patients on the study drug, and dyspnea led to discontinuation of the study drug in about 5 percent of patients on the drug.
"Efficacy was virtually identical with both ticagrelor doses," Sabatine said. "Risk of bleeding and dyspnea tended to be, as predicted, a bit more with the 90-mg than the 60-mg dose, but the trial wasn't designed to compare those two dose levels."
"Now that we have the evidence, when faced with a patient who has had a heart attack, based on these data, I would continue treatment with ticagrelor as long as the patient tolerated it," Sabatine said.
INFORMATION:
AstraZeneca sponsored the trial and provided a grant to Brigham and Women's Hospital. Sabatine has received honoraria from the company.
This study was simultaneously published online in the New England Journal of Medicine at the time of presentation.
The ACC's Annual Scientific Session brings together cardiologists and cardiovascular specialists from around the world each year to share the newest discoveries in treatment and prevention. Follow @ACCMediaCenter and #ACC15 for the latest news from the meeting.
The American College of Cardiology is a 49,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.
SAN DIEGO (March 14, 2015) -- A study comparing the overall economics of computed tomographic angiography with functional stress tests for evaluating patients with symptoms suggestive of possible blocked coronary arteries found no significant differences in costs over three years. The study was presented at the American College of Cardiology's 64th Annual Scientific Session.
Although the angiography, scans of the heart referred to as CT angiography, initially appeared to provide some cost savings, this didn't hold up once the costs of subsequent testing and procedures ...
The studies below will be presented at the American College of Cardiology's 64th Annual Scientific Session the afternoon of Saturday, March 14.
1. Energy Drink Shown to Raise Resting Blood Pressure
Medical reports have linked energy drink consumption to adverse cardiac events such as changes in heart rhythm, heart attacks and even deaths in otherwise healthy people. To investigate how energy drinks affect the heart, researchers alternately gave a can of commercially available energy drink or a placebo drink to 25 healthy young adults (age 19-40 years) and assessed changes ...
Scientists of the University of Arizona's Lunar and Planetary Laboratory have taken to kites that they fly above lava flows blanketing the Hawaiian landscape to unravel the past mysteries that shaped Mars.
A kite, equipped with off-the-shelf instruments such as a camera, a GPS, and orientation sensors, scans the terrain from high above. The team then employs parallel computing and powerful software algorithms to assemble tens of thousands of images into extremely detailed and accurate 3D digital terrain models.
In terms of studying volcanic landscapes, the project is ...
SAN DIEGO, Calif. (March 16, 2015)-- As the nation's headlines turn more and more to issues of tolerance -- race, religion, free speech, same sex marriage -- research by San Diego State University Psychology Professor Jean M. Twenge shows that Americans are actually more tolerant than ever before.
In a paper released this month by the journal Social Forces, Twenge, along with Nathan T. Carter and Keith Campbell from the University of Georgia, found that Americans are now more likely to believe that people with different views and lifestyles can and should have the same ...
ANN ARBOR, Mich. -- Some of social media's greatest stars aren't even old enough to tweet: Pictures of kids playing dress up, having meltdowns and even in the bathtub adorn Facebook walls. Diaper-donning toddlers dancing to the likes of Beyonce and Taylor Swift rack up YouTube views. Countless blogs share stories about everything from potty training to preschool struggles.
Today's University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health finds that this so-called "sharenting" isn't going anywhere anytime soon, with more than half of mothers ...
After many years of speculation, it has finally been established that hydrazine is not a prevalent contaminant in contemporary smokeless tobacco products (STPs).
The presence of hydrazine has only been reported once in a limited sample of cigarette tobacco and tobacco smoke some 40 years ago1. But this study has been cited many times as evidence that hydrazine is present in smokeless tobacco products. To date, no one has examined STPs for its presence.
Hydrazine is found in maleic hydrazine, which is used as a sucker growth inhibitor on tobacco crops - suckers are ...
ROCHESTER, Minn. - Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings.
"Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries," says S. Vincent Rajkumar, M.D., of Mayo Clinic Cancer Center, who is one of the authors. "As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients."
Dr. Rajkumar and his colleague, ...
In a world first, a research team including James Cook University scientists has discovered how geckos manage to stay clean, even in dusty deserts.
The process, described in Interface, the prestigious journal of the Royal Society, may also turn out to have important human applications.
JCU's Professor Lin Schwarzkopf said the group found that tiny droplets of water on geckos, for instance from condensing dew, come into contact with hundreds of thousands of extremely small hair-like spines that cover the animals' bodies.
"If you have seen how drops of water roll ...
A rare and threatened Caribbean coral species has for the first time been successfully bred and raised in the lab, according to research published in the open access journal BMC Ecology.
The study provides the first photos and documentation of juveniles of this species, and could provide information to help bolster local coral reef conservation. The team also plans to 'out-plant' these lab-grown juveniles in the wild which could help populations become more resilient to climate change.
The findings will be presented in a talk at the annual TED Conference in Vancouver ...
New research has discredited the popular belief that street lighting is attractive to common bats. The study, carried out by scientists from the University of Exeter and Bat Conservation Ireland, found that bat activity was generally lower in street-lit areas than in dark locations with similar habitat. The findings have important implications for conservation, overturning the previous assumption that common bats benefited from street-lights because they could feed on the insects that congregated around them.
The research, published in the journal Philosophical Transactions ...
